AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 207 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $221,000 | +67.4% | 23,545 | +36.5% | 0.00% | +100.0% |
| Q2 2020 | $132,000 | +25.7% | 17,252 | +1.1% | 0.00% | 0.0% |
| Q1 2020 | $105,000 | -25.0% | 17,064 | +48.4% | 0.00% | 0.0% |
| Q4 2019 | $140,000 | +5.3% | 11,498 | -0.0% | 0.00% | 0.0% |
| Q3 2019 | $133,000 | +14.7% | 11,499 | -0.6% | 0.00% | 0.0% |
| Q2 2019 | $116,000 | -24.2% | 11,565 | -2.9% | 0.00% | -33.3% |
| Q1 2019 | $153,000 | -15.0% | 11,914 | +0.6% | 0.00% | -25.0% |
| Q4 2018 | $180,000 | -70.0% | 11,842 | +7.9% | 0.00% | -63.6% |
| Q1 2015 | $600,000 | -20.8% | 10,980 | -38.2% | 0.01% | 0.0% |
| Q4 2014 | $758,000 | – | 17,780 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,390,000 | $33,584,000 | 1.92% |
| Bleichroeder LP | 1,299,994 | $9,945,000 | 1.76% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $31,518,000 | 1.38% |
| Palo Alto Investors LP | 2,959,587 | $22,641,000 | 1.36% |
| Permanens Capital L.P. | 359,461 | $2,750,000 | 1.04% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,607 | $242,000 | 0.19% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $2,662,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 795,611 | $6,086,000 | 0.07% |
| Teza Capital Management LLC | 23,269 | $178,000 | 0.04% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $297,000 | 0.03% |